T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Apple
AAPL
|
+$4.53B |
| 2 |
Broadcom
AVGO
|
+$1.7B |
| 3 |
GE Vernova
GEV
|
+$1.29B |
| 4 |
International Paper
IP
|
+$1.11B |
| 5 |
Tesla
TSLA
|
+$956M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.44B |
| 2 |
NVIDIA
NVDA
|
+$2.09B |
| 3 |
Constellation Energy
CEG
|
+$1.9B |
| 4 |
Qualcomm
QCOM
|
+$1.84B |
| 5 |
Amazon
AMZN
|
+$1.56B |
Sector Composition
| 1 | Technology | 34% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Communication Services | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Viridian Therapeutics
VRDN
$1.54B
| $578K | ﹤0.01% |
44,419
+13,050
| +42% | +$170K |
|
2127
Adaptive Biotechnologies
ADPT
$1.92B
| $575K | ﹤0.01% |
158,807
+3,578
| +2% | +$13K |
|
2128
Acco Brands
ACCO
$361M
| $574K | ﹤0.01% |
121,937
+3,151
| +3% | +$14.8K |
|
|
SVC
2129
Service Properties Trust
SVC
$476M
| $572K | ﹤0.01% |
111,148
+10,578
| +11% | +$54.4K |
|
|
UMH
2130
UMH Properties
UMH
$1.29B
| $571K | ﹤0.01% |
35,689
+3,112
| +10% | +$49.8K |
|
2131
Jamf
JAMF
$1.41B
| $570K | ﹤0.01% |
34,488
+3,382
| +11% | +$55.9K |
|
2132
Janus International
JBI
$1.44B
| $570K | ﹤0.01% |
45,095
+20,817
| +86% | +$263K |
|
2133
ProAssurance
PRA
$1.22B
| $570K | ﹤0.01% |
46,636
+2,313
| +5% | +$28.3K |
|
2134
Trump Media & Technology Group
DJT
$4.75B
| $570K | ﹤0.01% |
+17,383
| New | +$570K |
|
2135
Kforce
KFRC
$567M
| $570K | ﹤0.01% |
9,166
+596
| +7% | +$37.1K |
|
2136
Xperi
XPER
$279M
| $568K | ﹤0.01% |
69,166
+6,318
| +10% | +$51.9K |
|
2137
Ecovyst
ECVT
$1.06B
| $567K | ﹤0.01% |
63,122
+10,524
| +20% | +$94.5K |
|
2138
Century Aluminum
CENX
$2.44B
| $566K | ﹤0.01% |
33,763
-250
| -0.7% | -$4.19K |
|
2139
Central Pacific Financial
CPF
$826M
| $558K | ﹤0.01% |
26,320
+813
| +3% | +$17.2K |
|
2140
Forrester Research
FORR
$195M
| $557K | ﹤0.01% |
32,607
+3,348
| +11% | +$57.2K |
|
2141
PRA Group
PRAA
$657M
| $557K | ﹤0.01% |
28,327
+1,168
| +4% | +$23K |
|
2142
Unitil
UTL
$827M
| $557K | ﹤0.01% |
10,749
+460
| +4% | +$23.8K |
|
2143
Arcus Biosciences
RCUS
$1.23B
| $556K | ﹤0.01% |
36,498
+1,734
| +5% | +$26.4K |
|
2144
Digimarc
DMRC
$204M
| $555K | ﹤0.01% |
17,871
+2,686
| +18% | +$83.4K |
|
2145
Heritage Financial
HFWA
$833M
| $554K | ﹤0.01% |
30,706
+922
| +3% | +$16.6K |
|
2146
Crescent Energy
CRGY
$2.21B
| $550K | ﹤0.01% |
46,363
+8,364
| +22% | +$99.2K |
|
2147
Pathward Financial
CASH
$1.72B
| $549K | ﹤0.01% |
9,689
+509
| +6% | +$28.8K |
|
2148
Arcutis Biotherapeutics
ARQT
$2.07B
| $548K | ﹤0.01% |
58,902
+11,149
| +23% | +$104K |
|
2149
Heidrick & Struggles
HSII
$1.03B
| $548K | ﹤0.01% |
17,350
+674
| +4% | +$21.3K |
|
2150
Amneal Pharmaceuticals
AMRX
$3.14B
| $547K | ﹤0.01% |
86,027
+4,763
| +6% | +$30.3K |
|